19F and 1H MRI detection of amyloid β plaques in vivo
Abstract
Formation of senile plaques composed of amyloid beta peptide, a pathological hallmark of Alzheimer disease, in human brains precedes disease onset by many years. Noninvasive detection of such plaques could be critical in presymptomatic diagnosis and could contribute to early preventive treatment strategies. Using amyloid precursor protein (APP) transgenic mice as a model of amyloid beta amyloidosis, we demonstrate here that an intravenously administered (19)F-containing amyloidophilic compound labels brain plaques and allows them to be visualized in living mice by magnetic resonance imaging (MRI) using (19)F and (1)H. Our findings provide a new direction for specific noninvasive amyloid imaging without the danger of exposure to radiation. This approach could be used in longitudinal studies in mouse models of Alzheimer disease to search for biomarkers associated with amyloid beta pathology as well as to track disease course after treatment with candidate medications.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The plaques showed hypointensity in MRI images and increased with age in both cortex and hippocampus regions, consistent with previous findings.
“The plaques showed hypointensity in MRI images and increased with age in both cortex and hippocampus regions, which is consistent with several previous findings (Higuchi et al., 2005; Meadowcroft et al., 2009).”
From Age-dependent microstructure alterations in 5xFAD mice by high-resolution diffusion tensor imaging (2022) · cites this paper as Higuchi et al., 2005
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · see citing works
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works
RARE imaging: A fast imaging method for clinical MR
Hennig, J., Nauerth, A., & Friedburg, H. (1986) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910030602 · Cited by 2,088 · see citing works
Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease
Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · cited 1× · see citing works
“Although plaques by themselves may not be a direct cause of Alzheimer disease symptoms, a noninvasive method to detect them in the brain will allow diagnosis and preventive treatment of affected individuals before neurological symptoms and irreversible neurodegeneration occu”
MethodBeta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324 · see citing works
Shoghi, K. I., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petrič, A., Huang, S., et al. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00004 · Cited by 774 · see citing works
Alzheimer's Disease: A Central Role for Amyloid
Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 752 · see citing works
Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”
The Ronald and Nancy Reagan Research Institute of the Alzheimer’s Association and, & National Institute on Aging Working Group (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00022-0 · Cited by 702 · see citing works
Saido, T. C., Iwatsubo, T., Mann, D. M. A., Shimada, H., Ihara, Y., & Kawashima, S. (1995) · Neuron · doi:10.1016/0896-6273(95)90301-1 · Cited by 587 · see citing works
PET imaging of amyloid in Alzheimer's disease
Nordberg, A. K. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00853-1 · Cited by 462 · see citing works
Bacskai, B. J., Kajdasz, S. T., Christie, R. H., Carter, C., Games, D., Seubert, P. A., Schenk, D., & Hyman, B. T. (2001) · Nature Medicine · doi:10.1038/85525 · Cited by 445 · see citing works
Mathis, C. A., Bacskai, B. J., Kajdasz, S. T., McLellan, M. E., Frosch, M. P., Hyman, B. T., Holt, D. P., Wang, Y., Huang, G.-F., Debnath, M. L., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00734-x · Cited by 404 · see citing works
The Molecular and Genetic Basis of Neurological Disease
Trojanowski, J. Q. (1993) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199309000-00013 · Cited by 341 · see citing works
Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging
Wadghiri, Y. Z., Sigurdsson, E. M., Sadowski, M. J., Elliott, J. I., Li, Y., Scholtzova, H., Tang, C. Y., Aguinaldo, G., Pappolla, M. A., Duff, K., et al. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10529 · Cited by 273 · see citing works
Bacskai, B. J., Hickey, G. A., Skoch, J. M., Kajdasz, S. T., Wang, Y., Huang, G.-F., Mathis, C. A., Klunk, W. E., & Hyman, B. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034101100 · Cited by 255 · see citing works
Detection of neuritic plaques in Alzheimer’s disease by magnetic resonance microscopy
Benveniste, H., Einstein, G., Kim, K. R., Hulette, C., & Johnson, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14079 · Cited by 238 · see citing works
Molecular Targeting of Alzheimer's Amyloid Plaques for Contrast-Enhanced Magnetic Resonance Imaging
Poduslo, J. F., Wengenack, T. M., Curran, G. L., Wısnıewskı, T., Sigurdsson, E. M., Macura, S. I., Borowski, B., & Jack, C. R. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0550 · Cited by 216 · see citing works
In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease
Skovronsky, D., Zhang, B., Kung, M., Kung, H. F., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7609 · Cited by 212 · see citing works
IMPY: an improved thioflavin-T derivative for in vivo labeling of β-amyloid plaques
Kung, M., Hou, C., Zhuang, Z., Zhang, B., Skovronsky, D., Trojanowski, J. Q., Lee, V. M. ‐., & Kung, H. F. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03436-4 · Cited by 196 · see citing works
Radioiodinated Styrylbenzenes and Thioflavins as Probes for Amyloid Aggregates
Zhuang, Z.-P., KUNG, M. ‐., Hou, C., Skovronsky, D., Gur, T., Plößl, K., Trojanowski, J. Q., Lee, V. M.-Y., & Kung, H. F. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010045q · Cited by 196 · see citing works
Jack, C. R., Garwood, M., Wengenack, T. M., Borowski, B., Curran, G. L., Lin, J., Adriany, G., Gröhn, O. H. J., Grimm, R. C., & Poduslo, J. F. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20266 · Cited by 196 · see citing works
MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease
Helpern, J. A., Lee, P., Falangola, M. F., Dyakin, V. V., Bogart, A., Ardekani, B. A., Duff, K., Branch, C. A., Wısnıewskı, T., de Leon, M. J., et al. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20038 · Cited by 105 · see citing works
Styrylbenzoxazole Derivatives forIn VivoImaging of Amyloid Plaques in the Brain
Okamura, N., Suemoto, T., Shimadzu, H., Suzuki, M., Shiomitsu, T., Akatsu, H., Yamamoto, T., Staufenbiel, M., Yanai, K., Arai, H., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4456-03.2004 · Cited by 100 · see citing works
Lee, P., Falangola, M. F., Nixon, R. A., Duff, K., & Helpern, J. A. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20196 · Cited by 97 · see citing works
Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging
Zhang, J., Yarowsky, P., Gordon, M. N., Carlo, G. D., Munireddy, S., van Zijl, P. C. M., & Mori, S. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10730 · Cited by 89 · see citing works
Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques
Sato, K., Higuchi, M., Iwata, N., Saido, T. C., & Sasamoto, K. (2004) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2004.02.013 · Cited by 82 · see citing works
In vivo amyloid imaging in Alzheimer?s disease
Sair, H. I., Doraiswamy, P. M., & Petrella, J. R. (2004) · Neuroradiology · doi:10.1007/s00234-003-1034-9 · Cited by 50 · see citing works
Johnson, M. A., & Pinto, B. M. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.09.041 · Cited by 33 · see citing works
Metabolism and Alzheimer’s Disease
Blass, J. P. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-661-4_4 · Cited by 20 · see citing works
A-Beta Metabolism and Alzheimer's Disease
Saido, T. C. (2003) · CRC Press eBooks · doi:10.1201/9781498713641 · Cited by 15 · see citing works
Constantinidis, J. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90811-d · Cited by 4 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · see citing works
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2005) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2005.06.003 · Cited by 1,233 · see citing works
Challenges for Molecular Magnetic Resonance Imaging
Terreno, E., Castelli, D. D., Viale, A., & Aime, S. (2010) · Chemical Reviews · doi:10.1021/cr100025t · Cited by 852 · see citing works
Maruyama, M., Shimada, H., Suhara, T., Shinotoh, H., Ji, B., Maeda, J., Zhang, M.-R., Trojanowski, J. Q., Lee, V. M.-Y., Ono, M., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.037 · Cited by 760 · see citing works
Animal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676 · see citing works
Advanced functional materials based on polyhedral oligomeric silsesquioxane (POSS)
Tanaka, K., & Chujo, Y. (2011) · Journal of Materials Chemistry · doi:10.1039/c1jm14231c · Cited by 490 · see citing works
Ran, C., Xu, X., Raymond, S. B., Ferrara, B. J., Neal, K. L., Bacskai, B. J., Medarova, Z. O., & Moore, A. V. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9047043 · Cited by 487 · see citing works
Congo red and protein aggregation in neurodegenerative diseases
Frid, P., Anisimov, S. V., & Popović, N. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.08.001 · Cited by 398 · see citing works
Zhang, X., Tian, Y., Zeng, L., Tian, X., Sun, H., Liu, H. S., Moore, A. V., & Ran, C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405239v · Cited by 359 · see citing works
Sharma, P., Srivastava, P., Seth, A., Tripathi, P. N., Banerjee, A. G., & Shrivastava, S. K. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.006 · Cited by 331 · see citing works
Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., Staufenbiel, M., Iwata, N., Ono, M., Saido, T. C., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0673-07.2007 · Cited by 300 · see citing works
Self-citationParallel findings in age-related macular degeneration and Alzheimer’s disease
Ohno-Matsui, K. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.02.004 · Cited by 280 · see citing works
Paramagnetic Relaxation-Based 19F MRI Probe To Detect Protease Activity
Mizukami, S., Takikawa, R., Sugihara, F., Hori, Y., Tochio, H., Walchli, M. R., Shirakawa, M., & Kikuchi, K. (2007) · Journal of the American Chemical Society · doi:10.1021/ja077058z · Cited by 254 · see citing works
Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics
Masters, C. L., Cappai, R., Barnham, K. J., & Villemagne, V. L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03989.x · Cited by 237 · see citing works
Takaoka, Y., Sakamoto, T., Tsukiji, S., Narazaki, M., Matsuda, T., Tochio, H., Shirakawa, M., & Hamachi, I. (2009) · Nature Chemistry · doi:10.1038/nchem.365 · Cited by 231 · see citing works
Metabolism of amyloid-β peptide and Alzheimer's disease
Iwata, N., Higuchi, M., & Saido, T. C. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.010 · Cited by 216 · see citing works
Jackson, J. C., Hammill, J. T., & Mehl, R. A. (2007) · Journal of the American Chemical Society · doi:10.1021/ja064661t · Cited by 211 · see citing works
In vivo imaging of the diseased nervous system
Misgeld, T., & Kerschensteiner, M. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1905 · Cited by 197 · see citing works
New frontiers and developing applications in 19F NMR
Yu, J.-X., Hallac, R. R., Chiguru, S., & Mason, R. P. (2012) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2012.10.001 · Cited by 198 · see citing works
Recent Progress in Alzheimer’s Disease Research, Part 3: Diagnosis and Treatment
Hane, F. T., Robinson, M. J., Lee, B. Y., Bai, O., Leonenko, Z., & Albert, M. S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160907 · Cited by 200 · see citing works
Long-Term In Vivo Imaging of Fibrillar Tau in the Retina of P301S Transgenic Mice
Schön, C., Hoffmann, N. A., Ochs, S. M., Burgold, S., Filser, S., Steinbach, S., Seeliger, M. W., Arzberger, T., Goedert, M., Kretzschmar, H. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0053547 · Cited by 192 · see citing works
Propagation of pathological α-synuclein in marmoset brain
Shimozawa, A., Ono, M., Takahara, D., Tarutani, A., Imura, S., Masuda‐Suzukake, M., Higuchi, M., Yanai, K., Hisanaga, S., & Hasegawa, M. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0413-0 · Cited by 190 · see citing works
BODIPY-Based Molecular Probe for Imaging of Cerebral β-Amyloid Plaques
Ono, M., Watanabe, H., Kimura, H., & Saji, H. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn3000058 · Cited by 164 · see citing works
Hammill, J. T., Miyake-Stoner, S. J., Hazen, J. L., Jackson, J. C., & Mehl, R. A. (2007) · Nature Protocols · doi:10.1038/nprot.2007.379 · Cited by 158 · see citing works
The Amyloid–Congo Red Interface at Atomic Resolution
Schütz, A. K., Soragni, A., Hornemann, S., Aguzzi, A., Ernst, M., Böckmann, A., & Meier, B. H. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201008276 · Cited by 154 · see citing works
Yanagisawa, D., Shirai, N., Amatsubo, T., Taguchi, H., Hirao, K., Urushitani, M., Morikawa, S., Inubushi, T., Kato, M. G., Kato, F., et al. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.142 · Cited by 151 · see citing works
Jack, C. R., Wengenack, T. M., Reyes, D. A., Garwood, M., Curran, G. L., Borowski, B. J., Lin, J., Preboske, G. M., Holasek, S. S., Adriany, G., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2588-05.2005 · Cited by 148 · see citing works
Maeda, J., Zhang, M.-R., Okauchi, T., Ji, B., Ono, M., Hattori, S., Kumata, K., Iwata, N., Saido, T. C., Trojanowski, J. Q., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3076-10.2011 · Cited by 136 · see citing works
Dual‐Function Probe to Detect Protease Activity for Fluorescence Measurement and 19F MRI
Mizukami, S., Takikawa, R., Sugihara, F., Shirakawa, M., & Kikuchi, K. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200806328 · Cited by 142 · see citing works
Fu, H., Cui, M., Zhao, L., Tu, P., Zhou, K., Dai, J., & Liu, B. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00861 · Cited by 136 · see citing works
Yang, J., Yin, W., Van, R., Yin, K., Wang, P., Zheng, C., Zhu, B., Ran, K., Zhang, C., Kumar, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17783-4 · Cited by 123 · see citing works
Smart optical probes for near-infrared fluorescence imaging of Alzheimer’s disease pathology
Raymond, S. B., Skoch, J. M., Hills, I. D., Nesterov, E. E., Swager, T. M., & Bacskai, B. J. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0708-7 · Cited by 123 · see citing works
Negahdary, M., & Heli, H. (2019) · Talanta · doi:10.1016/j.talanta.2019.01.109 · Cited by 118 · see citing works
<i>In Vivo</i> mouse imaging and spectroscopy in drug discovery
Beckmann, N., Kneuer, R., Gremlich, H., Karmouty‐Quintana, H., Blé, F., & Müller, M. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1153 · Cited by 118 · see citing works
Yuan, Y., Sun, H., Ge, S., Wang, M., Zhao, H., Wang, L., An, L., Zhang, J., Zhang, H., Hu, B., et al. (2014) · ACS Nano · doi:10.1021/nn5062657 · Cited by 115 · see citing works
Sodium MR Imaging Detection of Mild Alzheimer Disease: Preliminary Study
Mellon, E. A., Pilkinton, D. T., Clark, C., Elliott, M. A., Witschey, W. R. T., Borthakur, A., & Reddy, R. D. (2009) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1495 · Cited by 115 · see citing works
Amiri, H., Saeidi, K., Borhani, P., Manafirad, A., Ghavami, M., & Zerbi, V. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn4001582 · Cited by 114 · see citing works
Chalmers, K., Luca, E. D., Hogg, N. H. M., Kenwright, A. M., Kuprov, I., Parker, D., Botta, M., Wilson, J. I., & Blamire, A. M. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200902300 · Cited by 113 · see citing works
Challenges for molecular neuroimaging with MRI
Lelyveld, V. S., Atanasijevic, T., & Jasanoff, A. (2010) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.20221 · Cited by 106 · see citing works
Fluorinated contrast agents for magnetic resonance imaging; a review of recent developments
Knight, J. C., Edwards, P. G., & Paisey, S. J. (2011) · RSC Advances · doi:10.1039/c1ra00627d · Cited by 108 · see citing works
Yuan, Y., Ge, S., Sun, H., Dong, X., Zhao, H., An, L., Zhang, J., Wang, J., Hu, B., & Liang, G. (2015) · ACS Nano · doi:10.1021/acsnano.5b00287 · Cited by 105 · see citing works
Quantitative magnetic resonance fluorine imaging: today and tomorrow
Chen, J., Lanza, G. M., & Wickline, S. A. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.87 · Cited by 104 · see citing works
Sillerud, L. O., Solberg, N. O., Chamberlain, R., Orlando, R. A., Heidrich, J. E., Brown, D. C., Brady, C. I., Jagt, T. A. V., Garwood, M., & Jagt, D. L. V. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121171 · Cited by 103 · see citing works
Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease
Saido, T. C., & Iwata, N. (2006) · Neuroscience Research · doi:10.1016/j.neures.2005.12.015 · Cited by 101 · see citing works
Mechanistic involvement of the calpain‐calpastatin system in Alzheimer neuropathology
Higuchi, M., Iwata, N., Matsuba, Y., Takano, J., Suemoto, T., Maeda, J., Ji, B., Ono, M., Staufenbiel, M., Suhara, T., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-187740 · Cited by 102 · see citing works
Araya, R., Noguchi, T., Yuhki, M., Kitamura, N., Higuchi, M., Saido, T. C., Seki, K., Itohara, S., Kawano, M., Tanemura, K., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.010 · Cited by 98 · see citing works
Amyloid imaging in Alzheimer??s disease
Nordberg, A. K. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3281a47744 · Cited by 97 · see citing works
Synthesis and Evaluation of Partly Fluorinated Block Copolymers as MRI Imaging Agents
Peng, H., Blakey, I., Dargaville, B. L., Rasoul, F. A., Rose, S., & Whittaker, A. K. (2009) · Biomacromolecules · doi:10.1021/bm801136m · Cited by 97 · see citing works
The ART of Loss: Aβ Imaging in the Evaluation of Alzheimer’s Disease and other Dementias
Villemagne, V. L., Fodero‐Tavoletti, M. T., Pike, K. E., Cappai, R., Masters, C. L., & Rowe, C. C. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8019-y · Cited by 97 · see citing works
ABCA1 influences neuroinflammation and neuronal death
Karasinska, J. M., de Haan, W., Franciosi, S., Ruddle, P., Fan, J., Kruit, J. K., Stukas, S., Lütjohann, D., Gutmann, D. H., Wellington, C. L., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.01.018 · Cited by 104 · see citing works
A review of β-amyloid neuroimaging in Alzheimer's disease
Adlard, P. A., Tran, B. A., Finkelstein, D. I., Desmond, P. M., Johnston, L. A., Bush, A. I., & Egan, G. F. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00327 · Cited by 93 · see citing works
ANCA: A Family of Fluorescent Probes that Bind and Stain Amyloid Plaques in Human Tissue
Chang, W. M., Dakanali, M., Capule, C. C., Sigurdson, C. J., Yang, J., & Theodorakis, E. A. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200018v · Cited by 90 · see citing works
Yanagisawa, D., Amatsubo, T., Morikawa, S., Taguchi, H., Urushitani, M., Shirai, N., Hirao, K., Shiino, A., Inubushi, T., & Tooyama, I. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.071 · Cited by 88 · see citing works
Multifunctional Core–Shell Silica Nanoparticles for Highly Sensitive 19F Magnetic Resonance Imaging
Matsushita, H., Mizukami, S., Sugihara, F., Nakanishi, Y., Yoshioka, Y., & Kikuchi, K. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308500 · Cited by 87 · see citing works
Styryl‐Based Compounds as Potential in vivo Imaging Agents for β‐Amyloid Plaques
Li, Q., Min, J., Ahn, Y., Namm, J., Kim, E. M., Lui, R., Kim, H. Y., Ji, Y., Wu, H., Wısnıewskı, T., et al. (2007) · ChemBioChem · doi:10.1002/cbic.200700154 · Cited by 86 · see citing works
A review of genome mutation and Alzheimer's disease
Thomas, P., & Fenech, M. F. (2006) · Mutagenesis · doi:10.1093/mutage/gel055 · Cited by 85 · see citing works
Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice
Ni, R., Chen, Z., Deán‐Ben, X. L., Voigt, F. F., Kirschenbaum, D. S., Shi, G., Villois, A., Zhou, Q., Crimi, A., Arosio, P., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00906-1 · Cited by 83 · see citing works
Current trends in blood biomarker detection and imaging for Alzheimer’s disease
Hu, S., Yang, C., & Luo, H. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114278 · Cited by 84 · see citing works
Watanabe, H., Ono, M., Matsumura, K., Yoshimura, M., Kimura, H., & Saji, H. (2013) · Molecular Imaging · doi:10.2310/7290.2013.00049 · Cited by 79 · see citing works
Metalloporphyrins and Functional Analogues as MRI Contrast Agents
Ni, Y. (2008) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/157340508784356789 · Cited by 78 · see citing works
Magnetic resonance imaging of Alzheimer’s disease
Lehéricy, S., Marjańska, M., Mesrob, L., Sarazin, M., & Kinkingnéhun, S. (2006) · European Radiology · doi:10.1007/s00330-006-0341-z · Cited by 73 · see citing works
Jack, C. R., Marjańska, M., Wengenack, T. M., Reyes, D. A., Curran, G. L., Lin, J., Preboske, G. M., Poduslo, J. F., & Garwood, M. (2007) · The Neuroscientist · doi:10.1177/1073858406295610 · Cited by 76 · see citing works
Braakman, N., Matysik, J., van Duinen, S. G., Verbeek, F. J., Schliebs, R., de Groot, H. J. M., & Alia, A. (2006) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20675 · Cited by 77 · see citing works
Takaoka, Y., Kiminami, K., Mizusawa, K., Matsuo, K., Narazaki, M., Matsuda, T., & Hamachi, I. (2011) · Journal of the American Chemical Society · doi:10.1021/ja203996c · Cited by 77 · see citing works
Efhc1 deficiency causes spontaneous myoclonus and increased seizure susceptibility
Suzuki, T., Miyamoto, H., Nakahari, T., Inoue, I., Suemoto, T., Jiang, B., Hirota, Y., Itohara, S., Saido, T. C., Tsumoto, T., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp006 · Cited by 76 · see citing works
Liu, K., Guo, T. L., Chojnacki, J. E., Lee, H., Wang, X., Siedlak, S. L., Rao, W., Zhu, X., & Zhang, S. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200122j · Cited by 75 · see citing works
Recent developments in carbonylation chemistry using [ 13 C]CO, [ 11 C]CO, and [ 14 C]CO
Nielsen, D. U., Neumann, K. T., Lindhardt, A. T., & Skrydstrup, T. (2018) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.3645 · Cited by 74 · see citing works
Biological applications of near infrared fluorescence dye probes in monitoring Alzheimer’s disease
Gyasi, Y. I., Pang, Y., Li, X., Gu, J.-X., Cheng, X., Liu, J., Xu, T., & Liu, Y. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111982 · Cited by 72 · see citing works
Tanabe, K., Harada, H., Narazaki, M., Tanaka, K., Inafuku, K., Komatsu, H., Itô, T., Yamada, H., Chujo, Y., Matsuda, T., et al. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904953b · Cited by 72 · see citing works
Fluorine polymer probes for magnetic resonance imaging: quo vadis?
Jirák, D., Gálisová, A., Kolouchová, K., Babuka, D., & Hrubý, M. (2018) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-018-0724-6 · Cited by 69 · see citing works
Push–pull benzothiazole derivatives as probes for detecting β-amyloid plaques in Alzheimer’s brains
Ono, M., Hayashi, S., Kimura, H., Kawashima, H., Nakayama, M., & Saji, H. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.08.032 · Cited by 69 · see citing works
Keupp, J., Rahmer, J., Graesslin, I., Mazurkewitz, P., Schaeffter, T., Lanza, G. M., Wickline, S. A., & Caruthers, S. D. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22877 · Cited by 68 · see citing works
Fu, H., Cui, M., Tu, P., Pan, Z., & Liu, B. (2014) · Chemical Communications · doi:10.1039/c4cc04907a · Cited by 68 · see citing works
Kim, C.-B., Choi, Y. Y., Song, W. K., & Song, K. (2013) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.5.051205 · Cited by 66 · see citing works
Kouyoumdjian, H., Zhu, D. C., El-Dakdouki, M. H., Lorenz, K., Chen, J.-J., Li, W., & Huang, X. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn3002015 · Cited by 59 · see citing works
A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice
Sigurdsson, E. M., Wadghiri, Y. Z., Mosconi, L., Blind, J. A., Knudsen, E., Asuni, A. A., Scholtzova, H., Tsui, W. H., Li, Y., Sadowski, M. J., et al. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.12.018 · Cited by 66 · see citing works
Chen, C., Liang, Z., Zhou, B., Li, X., Lui, C., Ip, N. Y., & Qu, J. Y. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00306 · Cited by 63 · see citing works
Tanaka, K., Kitamura, N., Naka, K., & Chujo, Y. (2008) · Chemical Communications · doi:10.1039/b815022b · Cited by 65 · see citing works
19F MRI detection of β-galactosidase activity for imaging of gene expression
Mizukami, S., Matsushita, H., Takikawa, R., Sugihara, F., Shirakawa, M., & Kikuchi, K. (2011) · Chemical Science · doi:10.1039/c1sc00071c · Cited by 64 · see citing works
Polyfluorinated Bis-styrylbenzene β-Amyloid Plaque Binding Ligands
Flaherty, D. P., Walsh, S. M., Kiyota, T., Dong, Y., Ikezu, T., & Vennerstrom, J. L. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070085f · Cited by 64 · see citing works
Amyloid imaging: Past, present and future perspectives
Villemagne, V. L. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.01.005 · Cited by 64 · see citing works
Cheng, Y., Zhu, B., Deng, Y., & Zhang, Z. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00017 · Cited by 64 · see citing works
Liu, X., Su, X., Chen, M., Xie, Y., & Li, M. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115840 · Cited by 63 · see citing works
Giacomelli, C., Daniele, S., & Martini, C. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.017 · Cited by 64 · see citing works
Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice
Hoffmann, N. A., Dorostkar, M. M., Blumenstock, S., Goedert, M., & Herms, J. W. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-82 · Cited by 64 · see citing works
Lim, Y. T., Noh, Y., Cho, J., Han, J. H., Choi, B. S., Kwon, J.-N., Hong, K. S., Gokarna, A., Cho, Y., & Chung, B. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904472z · Cited by 60 · see citing works
Noda-Saita, K., Yoneyama, A., Shitaka, Y., Hirai, Y., Terai, K., Wu, J., Takeda, T., Hyodo, K., Osakabe, N., Yamaguchi, T., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.036 · Cited by 58 · see citing works
Dual 19F/1H MR Gene Reporter Molecules for in Vivo Detection of β-Galactosidase
Yu, J.-X., Kodibagkar, V. D., Hallac, R. R., Liu, L., & Mason, R. P. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200647q · Cited by 54 · see citing works
Alrfaei, B. M., Vemuganti, R., & Kuo, J. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080865 · Cited by 54 · see citing works
Gd3+ complexes conjugated to Pittsburgh compound B: potential MRI markers of β-amyloid plaques
Martins, A. F., Morfin, J., Geraldes, C. F. G. C., & Tóth, É. (2013) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-013-1055-8 · Cited by 52 · see citing works
Tanaka, K., Kitamura, N., & Chujo, Y. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100381x · Cited by 52 · see citing works
PicoGreen: a better amyloid probe than Thioflavin-T
Mora, A. K., Singh, P. K., Patro, B. S., & Nath, S. (2016) · Chemical Communications · doi:10.1039/c6cc05600h · Cited by 52 · see citing works
Magnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review
Pansieri, J., Gerstenmayer, M., Lux, F., Mériaux, S., Tillement, O., Forge, V., Larrat, B., & Marquette, C. (2018) · Nanomaterials · doi:10.3390/nano8090740 · Cited by 52 · see citing works
Multiphoton in vivo imaging of amyloid in animal models of Alzheimer’s disease
Dong, J., Revilla-Sanchez, R., Moss, S. J., & Haydon, P. G. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.007 · Cited by 50 · see citing works
Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice
Petiet, A., Santin, M. D., Bertrand, A., Wiggins, C. J., Petit, F., Houitte, D., Hantraye, P., Bénavidès, J., Debeir, T., Rooney, T., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.009 · Cited by 50 · see citing works
Cerebrospinal fluid and blood biomarkers in Alzheimer’s disease
Humpel, C. (2011) · World Journal of Psychiatry · doi:10.5498/wjp.v1.i1.8 · Cited by 51 · see citing works
Nurmi, L., Peng, H., Seppälä, J. V., Haddleton, D. M., Blakey, I., & Whittaker, A. K. (2010) · Polymer Chemistry · doi:10.1039/c0py00035c · Cited by 50 · see citing works
Baumann, B., Wöehrer, A., Ricken, G., Augustin, M., Mitter, C., Pircher, M., Kovács, G. G., & Hitzenberger, C. K. F. (2017) · Scientific Reports · doi:10.1038/srep43477 · Cited by 50 · see citing works
Ultra-High Field 7T MRI: A New Tool for Studying Alzheimer's Disease
Kerchner, G. A. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-0023 · Cited by 49 · see citing works
Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease
Larbanoix, L., Burtéa, C., Laurent, S., LEUVEN, F. V., Toubeau, G., Elst, L. V., & Müller, R. N. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.021 · Cited by 49 · see citing works
- Authors
- Higuchi, M., Iwata, N., Matsuba, Y., Sato, K., Sasamoto, K., & Saido, T. C.
- Affiliations
- RIKEN Center for Brain Science (JP)
- Corresponding author
- Higuchi, Makoto
- Saido, Takaomi C
- Venue
- Nature Neuroscience
- Published
- 2005-03-13
- Volume
- 8
- Issue
- 4
- Pages
- 527-533
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W1989252530
- Cited by
- 339
- References
- 32
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 9 · 2023: 8 · 2022: 14 · 2021: 14 · 2020: 7 · 2019: 3 · 2018: 15 · 2017: 13 · 2016: 15 · 2015: 16 · 2014: 17 · 2013: 27 · 2012: 15
- FWCI
- 17.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- RIKEN
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- amyloid plaques, Alzheimer's disease, 19F MRI, 1H MRI, amyloid imaging, amyloid precursor protein transgenic mice, non-invasive brain imaging, presymptomatic diagnosis, disease biomarkers
- MeSH terms
- Age Factors, Alzheimer Disease, Amyloidosis, Animals, Brain, Brain Chemistry, Cell Count, Disease Models, Animal, Dose-Response Relationship, Drug, Fluorescent Dyes, Humans, Immunohistochemistry, Magnetic Resonance Imaging, Memantine, Mice, Transgenic, Phosphopyruvate Hydratase, Radionuclide Imaging, Staining and Labeling, Time Factors, Tritium, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Imaging, Three-Dimensional, Mice, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review